The Vanguard Group Discloses Position in Mural Oncology

The Vanguard Group, Inc. has released an opening position disclosure under Rule 8.3 of the Irish Takeover Panel Act, 1997. The disclosure pertains to Mural Oncology plc, a company whose relevant securities Vanguard holds. As of May 14, 2025, Vanguard owns and controls 772,831 ordinary shares, representing 4.48% of Mural Oncology's relevant securities.

In recent dealings, Vanguard purchased 108 ordinary shares at a price of 2.56 USD per share and sold 36 shares at the same price. The disclosure confirms that no derivative transactions or other securities dealings were made during this period. No indemnity or informal arrangements relating to these securities exist, nor are there any plans concerning their future acquisition or disposal.